Ramadan Study 2015

Impact of an individualized type 2
diabetes education program on clinical
outcomes during Ramadan
Laura N McEwen,1
Mahmoud Ibrahim,2
Nahed M Ali,3
Samir H Assaad-Khalil,4
Hyam Refaat Tantawi,5
Gamela Nasr,3
Shayan Mohammadmoradi,6
Aly A Misha’l,7
Firas A Annabi,7
Ebtesam M Ba-Essa,8
Suhad M Bahijri,9
Jaakko Tuomilehto,10
Linda A Jaber,11
William H Herman,1
for the International Group for Diabetes and
Ramadan (IGDR)
To cite: McEwen LN,
Ibrahim M, Ali NM, et al.
Impact of an individualized
type 2 diabetes education
program on clinical outcomes
during Ramadan. BMJ Open
Diabetes Research and Care
2015;3:e000111.
doi:10.1136/bmjdrc-2015-
000111
Received 24 April 2015
Revised 22 May 2015
Accepted 29 May 2015
For numbered affiliations see
end of article.
Correspondence to
Dr Laura N McEwen;
lmattei@med.umich.edu
ABSTRACT
Objective: To determine if individualized education
before Ramadan results in a safer fast for people with
type 2 diabetes.
Methods: Patients with type 2 diabetes who received
care from participating clinics in Egypt, Iran, Jordan
and Saudi Arabia and intended to fast during Ramadan
2014 were prospectively studied. Twelve clinics
participated. Individualized education addressed meal
planning, physical activity, blood glucose monitoring
and acute metabolic complications and when deemed
necessary, provided an individualized diabetes
treatment plan.
Results: 774 people met study criteria, 515 received
individualized education and 259 received usual care.
Those who received individualized education were
more likely to modify their diabetes treatment plan
during Ramadan (97% vs 88%, p<0.0001), to perform
self-monitoring of blood glucose at least twice daily
during Ramadan (70% vs 51%, p<0.0001), and to
have improved knowledge about hypoglycemic signs
and symptoms (p=0.0007). Those who received
individualized education also reduced their body mass
index (−1.1±2.4 kg/m2
vs −0.2±1.7 kg/m2
, p<0.0001)
and glycated haemoglobin (−0.7±1.1% vs −0.1±1.3%,
p<0.0001) during Ramadan compared those who
received usual care. There were more mild (77% vs
67%, p=0.0031) and moderate (38% vs 19%,
p<0.0001) hypoglycemic events reported by
participants who received individualized education than
those who received usual care, but fewer reported
severe hypoglycemic events during Ramadan (23% vs
34%, p=0.0017).
Conclusions: This individualized education and
diabetes treatment program helped patients with type 2
diabetes lose weight, improve glycemic control and
achieve a safer fast during Ramadan.
INTRODUCTION
Fasting during the holy month of Ramadan
is one of the ﬁve pillars of Islam. Muslims
who fast during Ramadan abstain from
eating, drinking, using oral and injectable
medications, and smoking from before dawn
until after sunset; however, there are no
restrictions on food, ﬂuid or medication
intake between sunset and dawn. Most
people consume two meals per day during
Ramadan, one after sunset and the other
before dawn. According to religious tenets,
Muslims who are pregnant or sick are
exempted from fasting. Nevertheless, many
Muslims with diabetes choose to fast during
Ramadan, thereby creating a medical chal-
lenge for themselves and their healthcare
providers. It is important that medical profes-
sionals be aware of the changes in diet, phys-
ical activity and medication-taking associated
with fasting during Ramadan, the potential
risks (mainly hypoglycemia and hypergly-
cemia) and approaches to address those
changes and to mitigate those risks.
In September 2005, the American Diabetes
Association (ADA) published a working
group report on the management of diabetes
during Ramadan.1
This report was updated
in August 2010.2
Based on the recommenda-
tions in these reports, people with type 1 dia-
betes and pregnant women with diabetes
Key messages
▪ Those who received individualized education
before Ramadan were more likely to modify their
diabetes treatment plan during Ramadan, to
perform self-monitoring of blood glucose at least
twice daily and to have improved knowledge
about hypoglycemic signs and symptoms.
▪ Those who received individualized education
reduced their weight and glycated haemoglobin
during Ramadan compared to those who
received usual care, and were less likely to be
hospitalized.
▪ This individualized education and diabetes treat-
ment program can help patients with type 2 dia-
betes achieve a safer Ramadan fast.
BMJ Open Diabetes Research and Care 2015;3:e000111. doi:10.1136/bmjdrc-2015-000111 1
Open Access Research
group.bmj.comon June 17, 2015 - Published byhttp://drc.bmj.com/Downloaded from

should be strongly discouraged from fasting because of
the high risk of developing serious and potentially life-
threatening acute metabolic complications. People with
type 2 diabetes who wish to fast during Ramadan should
receive a full clinical assessment, Ramadan-focused edu-
cation and individualized treatment recommendations
before Ramadan in order to achieve a safer fast.
Since the ADA recommendations were published, two
studies have assessed the impact of diabetes education
programs on outcomes during Ramadan. The Ramadan
Education and Awareness in Diabetes (READ) Study
found that attending a structured education program
that provided recommendations for physical activity,
meal planning, glucose monitoring, hypoglycemia man-
agement,and dosage and timing of medications was asso-
ciated with a statistically significant weight loss of 0.7 kg
and a decrease in the number of hypoglycemic events
during Ramadan.3
However, this was a small (n=111 par-
ticipants), single site study in which the participants
volunteered and the controls declined to receive the
education program. The Ramadan Prospective Diabetes
Study also found that a structured education program
was effective in preventing serious complications of dia-
betes during Ramadan. This study was also a single site
study, the sample size was small (n=110 participants) and
there was no control group for comparison.4
A recent
study showed that patients who fast during Ramadan can
have a significant improvement in glycated haemoglobin
(HbA1c) if appropriate adjustments are made to their
antidiabetic regimens during Ramadan.5
This study was designed as a multination, multicenter,
prospective observational study with treatment allocation
at the clinic level. Its purpose was to examine if indivi-
dualized preRamadan education resulted in improved
clinical outcomes and a safer fast for people with type 2
diabetes. The individualized education program
addressed issues related to meal planning, physical activ-
ity, blood glucose monitoring and recognition and man-
agement of acute metabolic complications during the
month of Ramadan. A physician was also available to
perform an assessment and to provide individualized
recommendations to change medication management
to reduce the incidence of hypoglycemia, reduce fasting
and postprandial hyperglycemia and maintain weight or
facilitate weight loss during Ramadan.
METHODS
The study team included diabetes researchers from clin-
ical sites in Egypt, Iran, Jordan and Saudi Arabia, and
researchers from the USA. Researchers from the clinical
sites were responsible for partnering with clinics willing
to participate in the study. A total of 12 clinics were
recruited, 4 provided individualized education, 4 pro-
vided only usual care and at 4 additional clinics, con-
secutive patients were invited to be in the intervention
group until that group was complete. Thereafter, con-
secutive patients were invited to be in the control group.
At all clinics, eligible participants were identified as
patients who had been diagnosed by a physician with
type 2 diabetes, were not currently pregnant and did not
have illnesses that were contraindications to fasting
(ie, recent myocardial infarction, advanced liver disease
end-stage renal disease, cancer, recent surgery, etc).
Patients meeting the eligibility criteria who consented to
participate were asked to come to the clinic within
2 months before the start of Ramadan (May–June 2014)
for a preRamadan assessment, blood draw, survey and
either individualized patient education or usual care.
They were also asked to return to the clinic within
2 months after the end of Ramadan (August–September
2014) for a postRamadan assessment, blood draw, and
survey. Investigators at each clinic obtained approval to
conduct the study through their local ethical standards
boards and ensured that participants provided informed
consent and that patient confidentiality was maintained
as required by their local ethical standards boards.
Management and analyses of deidentified data were per-
formed at the University of Michigan. The University of
Michigan Institutional Review Board reviewed the study
and determined that the project was exempt and not
regulated since it involved only coded information that
could not be linked to a specific individual by the inves-
tigator(s) directly or indirectly through a coding system.
For the intervention, each participant received, on
average, 2 (range 1–7) 30 min to 1 h individualized
face-to-face education sessions delivered by dietitians,
diabetes specialist nurses or community link workers
who were trained by the site investigator. The sessions
were conducted either one-on-one or in a group format
in the preferred language of the patients. The program
addressed issues of meal planning, physical activity,
blood glucose monitoring and recognizing and man-
aging acute metabolic complications before and during
Ramadan. It was stressed that the diet during Ramadan
should not differ from a healthy mixed and balanced
diet encouraging slow energy-release foods and minimiz-
ing foods high in refined sugars and saturated fat.
Regular light and moderate physical activity was encour-
aged, however, strenuous physical activity immediately
before sunset was discouraged because of the risk of
hypoglycemia. Patients were educated that blood
glucose monitoring did not constitute breaking the fast
and were encouraged to test their blood glucose levels.
They were also taught to recognize the symptoms of
hypoglycemia and hyperglycemia, how to treat those
conditions and when to break the fast. The physician
provided specific recommendations for changing both
the dose and timing of sulfonylurea medications and
insulin. In addition, if the physician saw fit, he/she
recommended changes to the diabetes treatment
regimen so that it was more appropriate for Ramadan
and would be weight neutral or help the patient to
reduce weight.
Patients receiving only usual care received a copy of
the 2010 ADA guidelines for the management of
2 BMJ Open Diabetes Research and Care 2015;3:e000111. doi:10.1136/bmjdrc-2015-000111
Clinical care/education/nutrition/psychosocial research

diabetes while fasting during Ramadan in English or
Arabic. Since these guidelines have been available since
2005, they are likely to have been implemented in these
clinics for patients who intended to fast during
Ramadan and thus can be considered ‘usual care’.
Patients were excluded from the study if they did not
know their type of diabetes or reported type 1 diabetes
or gestational diabetes (N=49), did not fast during
Ramadan 2014 (N=34), or did not complete both a
preRamadan and postRamadan survey (N=153). Data
were analyzed for the 774 patients who reported that
they had type 2 diabetes, fasted for at least 2 days during
Ramadan 2014, and completed both preRamadan and
postRamadan surveys. Characteristics of patients at both
the preRamadan and postRamadan time points were
described in total, and separately for those who received
individualized education and those who received usual
care using means±SD and t tests for continuous vari-
ables, or number (per cent) and χ2
tests or Fishers exact
test for categorical variables.
Knowledge of diabetes risk, hypoglycemic and hyper-
glycemic symptoms, and actions to take when hypogly-
cemic were scored on 0–4 or 0–5 point scales with 1
point assigned for each correct yes/no answer.
Occurrence of mild hypoglycemia was determined by
self-report of symptoms of hunger, rapid heart rate,
anxiety, tremors, sweating or headache. Moderate hypo-
glycemia was defined as hypoglycemia that required the
assistance of another person, and severe hypoglycemia
was defined as hypoglycemia that required medical
assistance including emergency room or hospital care,
glucagon injection, or intravenous infusion of glucose.
Occurrence of mild hyperglycemia was defined as self-
report of symptoms of excessive thirst or increased urin-
ation. Severe hyperglycemia was defined as hypergly-
cemia that required medical assistance or emergency
room or hospital care, or treatment with insulin (if not
previously using insulin).
Changes in knowledge, weight, body mass index
(BMI) and HbA1c from before to after Ramadan were
calculated and described in total, and separately for
those who received individualised education and those
who received usual care. Differences were compared
using paired t tests. Analyses were conducted using SAS
V.9.3 (SAS Institute, Cary, North Carolina, USA).
RESULTS
We studied 774 patients with type 2 diabetes attending
clinics in Egypt, Iran, Jordan and Saudi Arabia who
fasted for ≥2 days during Ramadan 2014. The first
Egyptian site was an endocrinology practice that serves
∼4000 adult and geriatric patients in an urban area. The
second Egyptian site recruited patients from two clinics,
one urban and suburban, in which 2–5 generalists and
endocrinologists serve approximately 100 adult and geri-
atric patients with diabetes each day. The third Egyptian
site recruited patients from one urban clinic in which 10
generalists and endocrinologists serve approximately 400
adult and geriatric patients with diabetes each day. In all
four of the Egyptian clinics, intervention and control
patients were recruited in a sequential manner.
The two clinics in Iran were both located in a large
city. The control clinic had five physicians who serve
approximately 150 adult patients with diabetes per day.
The intervention clinic had nine physicians who serve
approximately 100 adult and geriatric patients with dia-
betes patients per day.
The two clinics in Jordan were located in a large city.
In both clinics, endocrinologists serve adult and geriatric
patients. The intervention clinic had two physicians who
serve approximately 1800 patients with diabetes per year
and the control clinic had one physician who serves
approximately 900 patients with diabetes per year.
There were two sites in Saudi Arabia. The first that
recruited from two urban clinics (one intervention and
one control). Each clinic had two generalist physicians
that serve a few hundred adult patients with diabetes.
The second site in Saudi Arabia recruited two urban
clinics in which endocrinologists serve adult patients
with diabetes. The intervention clinic had three physi-
cians and serves 120 patients with diabetes per day. The
control clinic had eight physicians and serves 250
patients with diabetes per day.
As shown in table 1, the overall mean age was 48
±10 years, 59% were female, and over 60% were at least
high school graduates. While there were more women
than men who were homemakers or who were not
employed (36% vs 25%), those who were employed were
equally likely to report that they worked indoors
or out-of-doors. The mean duration of diabetes was
9±5 years. Fifty-six per cent of patients used oral medica-
tions and/or non-insulin injectables to treat their dia-
betes. Twenty-five per cent used oral medications and/
or non-insulin injectables and insulin, 18% used insulin
only and 1% used diet alone to treat their diabetes. Of
those who reported using oral medications and/or non-
insulin injectables, 50% reported using a sulfonylurea.
Almost 75% of participants reported seeing an endo-
crinologist for their diabetes management. Most partici-
pants reported that they do not usually receive diabetes
education before Ramadan (86%) or during Ramadan
(82%). Sixteen per cent of people reported that they
didn’t usually receive advice about fasting during
Ramadan. Among those who reported receiving advice,
the advice was from a variety of sources including physi-
cians, religious authorities, family members and friends
but almost always included advice from a physician.
The intervention clinics recruited 515 participants
who received individualized education and the control
clinics recruited 259 participants who received only
usual care (table 1). The participants who received indi-
vidualized education were younger than those who
received usual care (47 vs 51 years old, p<0.0001), but
the individualized education and usual care participants
were similar with respect to sex, education, occupation,

duration of diabetes, current treatment for diabetes,
occurrence of previous hypoglycemic and hyperglycemic
events and type of provider seen for diabetes
management (table 1). Compared to the participants
who received usual care, participants who received indi-
vidualized education had lower body mass index
Table 1 Baseline characteristics of patients who had type 2 diabetes, completed preRamadan and postRamadan surveys,
and fasted ≥2 days during Ramadan 2014, stratified by control and intervention group
Characteristic Total population Control group Intervention group p Value
N 774 259 515
Age (years) (missing=34) 48±10 51±10 47±10 <0.0001
Sex (missing=3) 0.9268
Male 315 (41%) 106 (41%) 209 (41%)
Female 456 (59%) 152 (59%) 304 (59%)
Education
Male 0.2154
Illiterate 11 (3%) 7 (7%) 4 (2%)
Less than high school 95 (30%) 32 (30%) 63 (30%)
High school graduate 109 (34%) 35 (33%) 72 (34%)
Associates degree or higher 102 (32%) 32 (30%) 70 (33%)
Female (missing=1) 0.0323
Illiterate 38 (8%) 20 (13%) 18 (6%)
Less than high school 127 (28%) 46 (30%) 81 (27%)
High school graduate 171 (38%) 49 (32%) 122 (40%)
Associates degree or higher 119 (26%) 37 (24%) 82 (27%)
Occupation
Male (missing=14) 0.1783
Employed indoors 111 (37%) 34 (33%) 77 (39%)
Employed out-of-doors 115 (38%) 36 (35%) 79 (40%)
Homemaker or not employed 75 (25%) 32 (31%) 43 (22%)
Female (missing=15) 0.7127
Employed indoors 145 (33%) 48 (32%) 97 (33%)
Employed out-of-doors 137 (31%) 43 (29%) 94 (32%)
Homemaker or not employed 159 (36%) 57 (39%) 102 (35%)
Duration of diabetes (years) (missing=8) 9±5 10±6 9±4 0.0722
Current treatment for diabetes (missing=5) 0.1669
Diet and exercise only 3 (1%) 2 (1%) 1 (0%)
Oral medications (±non-insulin injectable) 434 (56%) 154 (60%) 280 (55%)
Oral medications (±non-insulin injectable) and insulin 192 (25%) 64 (25%) 128 (25%)
Insulin only 140 (18%) 38 (15%) 102 (20%)
Provider seen for diabetes management (missing=45) 0.3686
Primary care physician 192 (26%) 60 (24%) 132 (28%)
Endocrinologist 526 (72%) 190 (75%) 336 (71%)
Other 7 (1%) 1 (0%) 6 (1%)
None 4 (1%) 2 (1%) 2 (0%)
Who usually provides advice to you regarding fasting? (missing=20) <0.0001
Physician and Religious and family/friends 221 (29%) 61 (24%) 160 (32%)
Physician and Religious authority only 180 (24%) 46 (18%) 134 (27%)
Physician only 154 (20%) 49 (20%) 105 (21%)
No one 119 (16%) 73 (29%) 46 (9%)
Physician and family/friends 59 (8%) 14 (6%) 45 (9%)
Religious authority and family/friends 9 (1%) 2 (1%) 7 (1%)
Religious authority only 7 (1%) 3 (1%) 4 (1%)
Family and friends only 5 (1%) 2 (1%) 3 (1%)
Usually receive diabetes education…
Before Ramadan? (missing=51) 0.7634
Yes 103 (14%) 33 (14%) 70 (15%)
No 620 (86%) 208 (86%) 412 (85%)
During Ramadan? (missing=57) 0.0068
Yes 130 (18%) 30 (13%) 100 (21%)
No 587 (82%) 208 (87%) 379 (79%)
Data are expressed as mean±SD or N (per cent).

(BMI; 30±4 kg/m2
intervention vs 31±5 kg/m2
control,
p=0.0097) and were less likely to report never monitor-
ing their blood glucose while fasting (9% intervention vs
18% control, p=0.0021). HbA1c was similar (8.7±1.3%
intervention vs 8.9±1.7% control, p=0.2274).
While over 47% of participants fasted for the entire
month, people who received individualized education
fasted on average 1 day more than those who received
usual care (p=0.0257). As shown in table 2, the majority
of participants reported receiving diabetes education
before Ramadan 2014. However, this per cent was signiﬁ-
cantly higher for participants receiving individualized
education (98% vs 84%, p<0.0001). In order of decreas-
ing proportion, participants receiving individualized
education were more likely to be counseled on recogni-
tion and treatment of hypoglycemia, change in
Table 2 Outcomes for patients who had type 2 diabetes, completed preRamadan and postRamadan surveys and fasted
≥2 days during Ramadan, stratified by control and intervention group
N 774 259 515
Mean number of days fasted 26±4 26±4 27±4 0.0257
Did you receive diabetes education before Ramadan? (missing=3) <0.0001
Yes 721 (94%) 216 (84%) 505 (98%)
No 50 (6%) 41 (16%) 9 (2%)
For those who received education before Ramadan, the content of the diabetes education included…
Change in medication type 245 (32%) 19 (7%) 226 (44%) <0.0001
Change in medication dose 313 (40%) 43 (16%) 270 (52%) <0.0001
Change in medication timing 582 (75%) 165 (64%) 417 (81%) <0.0001
Change in frequency of glucose monitoring 392 (51%) 73 (28%) 319 (62%) <0.0001
Recognition and treatment of hypoglycemia 657 (85%) 190 (74%) 467 (91%) <0.0001
Recognition and treatment of hyperglycemia 381 (49%) 76 (29%) 305 (59%) <0.0001
Recognition of when to break the fast 389 (50%) 81 (31%) 308 (60%) <0.0001
Meal planning 362 (47%) 75 (29%) 287 (56%) <0.0001
Physical activity 332 (43%) 60 (23%) 272 (53%) <0.0001
Did you receive diabetes education during Ramadan? (missing=15) <0.0001
Yes 276 (36%) 28 (11%) 248 (49%)
No 483 (63%) 229 (89%) 254 (51%)
Were you advised by a physician to modify diabetes treatment plan during Ramadan? (missing=27) <0.0001
Yes 689 (92%) 202 (83%) 487 (97%)
No 58 (8%) 41 (17%) 17 (3%)
Did you modify diabetes treatment plan during Ramadan? (missing=8) <0.0001
Yes 720 (94%) 222 (88%) 498 (97%)
No 46 (6%) 29 (12%) 17 (3%)
How did you modify your treatment plan?
Changed medication type 204 (26%) 18 (7%) 186 (36%) <0.0001
Changed medication dose 554 (72%) 162 (63%) 392 (76%) <0.0001
Changed medication timing 675 (87%) 203 (78%) 472 (92%) <0.0001
Increased frequency of glucose monitoring 328 (42%) 72 (28%) 256 (50%) <0.0001
Changed diet 306 (40%) 51 (20%) 255 (50%) <0.0001
Changed physical activity 247 (32%) 34 (13%) 213 (41%) <0.0001
During Ramadan, symptoms of…
Mild hypoglycemia* 571 (74%) 174 (67%) 397 (77%) 0.0031
Moderate hypoglycemia† 244 (32%) 49 (19%) 195 (38%) <0.0001
Severe hypoglycemia‡ 208 (27%) 88 (34%) 120 (23%) 0.0017
Mild hyperglycemia§ 330 (44%) 111 (44%) 219 (43%) 0.8050
Severe hyperglycemia¶ 7 (1%) 4 (2%) 3 (1%) 0.2360
Hospitalized during Ramadan 0.0071
No 725 (99%) 241 (98%) 484 (99%)
Yes 7 (1%) 6 (2%) 1 (0%)
Data are expressed as mean±SD or N (per cent).
*Mild hypoglycemia: symptoms include hunger, rapid heart rate, anxiety, tremors, sweating, headache.
†Moderate hypoglycemia: symptoms of such severity that the participant required the assistance of another person.
‡Severe hypoglycemia: symptoms of such severity that the participant required professional medical assistance including emergency room or
hospital care or placement of an intravenous injection of glucose.
§Mild hyperglycemia: symptoms including excessive thirst or excessive urination with or without nausea.
¶Severe hyperglycemia: symptoms of such severity that the participant required professional medical assistance or emergency room or
hospital care, or treatment with insulin (if not taking previously).

medication timing, change in frequency of self-
monitoring of blood glucose, awareness of when to
break the fast, recognition and treatment of hypergly-
cemia, meal planning, physical activity, changes in medi-
cation dose and changes in medication type. Those
receiving individualized education were also signiﬁcantly
more likely to report receiving diabetes education
during Ramadan 2014 (49% vs 11%, p<0.0001), to be
advised by their physicians to modify their diabetes treat-
ment plan during Ramadan (97% vs 83%, p<0.0001)
and to modify their diabetes treatment plan during
Ramadan (97% vs 88%, p<0.0001). In modifying their
diabetes treatment plans, participants receiving indivi-
dualized education most often chose to change the
timing of their medication (92%) and change their
medication dose (76%) during Ramadan. About half of
those receiving individualized education increased their
frequency of self-monitoring of blood glucose (50%)
and changed their diet (50%), while fewer than half
changed their physical activity (41%) or changed their
medication type (36%) during Ramadan.
Participants receiving individualized education were
more likely to report symptoms of mild (77% vs 67%,
p=0.0031) and moderate (38% vs 19%, p<0.0001) hypo-
glycemia during Ramadan than those receiving usual
care. They were, however, less likely to report severe
hypoglycemia that required medical assistance, glucagon
injection or intravenous infusion of glucose (23% vs
34%, p=0.0017). Symptoms of mild and severe hypergly-
cemia were equally likely to be reported by those receiv-
ing individualized education or only usual care. One of
515 (0%) participants receiving individualized education
was hospitalized for intravenous therapy. In contrast, 6
of 259 (2%) participants receiving usual care reported
hospitalizations, 1 for hypoglycemic coma, 2 for
intravenous therapy, 1 for hyperglycemia, 1 for palpita-
tions and shortness of breath and 1 for unknown
reasons. The proportion of patients receiving individua-
lized education who were hospitalized was signiﬁcantly
less than the proportion receiving usual care
(p=0.0071).
When we examined changes in outcomes, participants
receiving individualized education had greater improve-
ment in knowledge of hypoglycemic symptoms, but
similar improvements in knowledge of hyperglycemic
symptoms and actions to take when hypoglycemic as par-
ticipants who received usual care (table 3). A greater
increase in the frequency of monitoring was seen in par-
ticipants receiving individualized education compared to
those receiving usual care. Eighty per cent of partici-
pants receiving individualized education increased their
glucose testing frequency during Ramadan compared to
58% receiving usual care. Of the 385 people receiving
individualized education who increased the frequency of
monitoring during Ramadan, the majority (68%) went
from monitoring once a day to twice a day.
There were improvements in weight, BMI and HbA1c
from before Ramadan to after Ramadan for partici-
pants receiving individualized education or only usual
care. These improvements were more marked in parti-
cipants receiving individualized education. On average,
those receiving individualized education lost 2.9±6.4 kg
during Ramadan compared to a loss of 0.5±4.6 kg
for those receiving usual care (p<0.0001). This corre-
sponded to a decrease in BMI of 1.1±2.4 kg/m2
and
0.2±1.7 kg/m2
in the intervention and control groups
(p<0.0001). HbA1c for participants receiving individua-
lized education improved by 0.7±1.1% and HbA1c for
participants receiving usual care improved by 0.1±1.3%
(p<0.0001).
Table 3 Changes from baseline to followup for patients who had type 2 diabetes, completed preRamadan and
postRamadan surveys and fasted ≥2 days during Ramadan
N 774 259 515
Knowledge
Hypoglycemic symptoms (0–5) 0.06±1.2 −0.14±1.1 0.16±1.2 0.0007
Hyperglycemic symptoms (0–5) 0.60±1.3 0.70±1.3 0.54±1.3 0.1139
Actions when hypoglycemic (0–5) 0.14±1.0 0.15±1.0 0.14±1.0 0.8301
Frequency of glucose monitoring while fasting (missing=104) <0.0001
Decreased 31 (5%) 16 (9%) 15 (3%)
Stayed the same 147 (22%) 63 (34%) 84 (17%)
Increased 492 (73%) 107 (58%) 385 (80%)
Of those who increased monitoring… (n=492) <0.0001
Never→when symptomatic/1×/2× daily 60 (12%) 29 (27%) 31 (8%)
Only when symptomatic→1×/2× daily 121 (25%) 27 (25%) 94 (24%)
1× daily→2× daily 311 (63%) 51 (48%) 260 (68%)
Weight (kg) (missing=19) −2.1±5.9 −0.5±4.6 −2.9±6.4 <0.0001
BMI (kg/m2
) (missing=53) −0.8±2.2 −0.2±1.7 −1.1±2.4 <0.0001
HbA1c (missing=43) −0.5±1.2 −0.1±1.3 −0.7±1.1 <0.0001
Data are expressed as mean change±SD or N (per cent).
BMI, body mass index; HbA1c, glycated haemoglobin.

DISCUSSION
Our study supports the use of a preRamadan diabetes
education program that includes individualized diabetes
treatment recommendations for patients with type 2 dia-
betes. While participants from both groups were gener-
ally not different in terms of their demographic
characteristics, duration of diabetes, treatments for dia-
betes and preRamadan weight and HbA1c levels, those
receiving individualized education had greater improve-
ments in weight and HbA1c over the month of
Ramadan. Those who received individualized education
were also more likely to increase self-monitoring of
blood glucose during Ramadan, had greater improve-
ments in knowledge of hypoglycemia and had less fre-
quent severe hypoglycemia.
The individualized preRamadan education program
used in this study was based on recommendations from
the 2005 and 2010 ADA working group reports on the
management of diabetes during Ramadan.1 2
These
reports focused on issues related to meal planning, phys-
ical activity, blood glucose monitoring and recognizing
and managing acute metabolic complications before
and during Ramadan. This type of education program
was similar to the program used in the READ study,3
which found a mean weight loss of 0.7 kg in the group
that received education compared to a 0.6 kg mean
weight gain in the control group. While we observed
weight loss in participants in both groups during
Ramadan, the difference was significantly greater in the
participants who received individualized education. The
READ study also showed a significant decrease in the
total number of hypoglycemic events in the group that
received education compared to the control group. Our
study showed more mild and moderate hypoglycemic
events in those who received individualized education.
This may have reflected ascertainment bias due to an
increase in self-monitoring of blood glucose in partici-
pants who received individualized education. There
were, however, fewer severe hypoglycemic events and
hospitalizations in those who received individualized
education. In sensitivity analyses, we found that there
were fewer severe hypoglycemic events among those who
used and did not use, insulin to treat their diabetes
during Ramadan (data not shown).
The education program delivered in the previously
reported Ramadan Prospective Diabetes Study4
also
included elements recommended by the ADA working
group and was similar to the education program used in
our study. Receiving diabetes education decreased the
number of hypoglycemic episodes and most participants
did not experience any acute complications of diabetes
during Ramadan. Our study extends those results. We
also studied patients in a control group who did not
receive individualized preRamadan education. This
group had more severe hypoglycemic events and more
hospitalizations than the participants receiving indivi-
dualized education. While the participants in our study
did not report in great detail the reasons for
hospitalization, if we assume ‘IV therapy’ was for admin-
istration of glucose or insulin, then five of the six hospi-
talizations among those who received only usual care
may have been for issues related to hypoglycemia or
hyperglycemia.
There were several limitations of our study. First,
almost 75% of participants in both groups reported
seeing endocrinologists for their diabetes management.
This is likely due to the fact that researchers were
responsible for recruiting at the and likely included
clinics that had the resources to deliver the interven-
tions. As a result, the clinics we studied may have pro-
vided better care than clinics not directed by
endocrinologists. Second, although four sites recruited
separate intervention and control clinics, four sites
sequentially enrolled intervention and control partici-
pants form the same clinics. This many have produced
contamination bias whereby people in the control group
were exposed to the intervention. If so, this would have
reduced the apparent impact of the intervention. Third,
we did not analyze results of self-monitoring of blood
glucose. Although we asked participants in both groups
to record at least two blood glucose values daily, we
obtained logs from only 279 (54%) of participants who
received individualized education and 52 (20%) of parti-
cipants who received only usual care. Owing to the low
response rates, we did not include these measurements
in the analysis. Fourth, we had to exclude 16% (n=153)
of the original study population because those partici-
pants did not return for the postRamadan study visit.
This may have introduced selection bias, as those who
did return for a postRamadan study visit may have been
more likely to have benefited from participation. In fact,
the demographic characteristics of the population that
did not return for a postRamadan visit differed from the
study population. The non-responders were older (56
±10 years, p<0.0001), were more likely to be men (51%,
p=0.0212), had longer durations of diabetes (12
±8 years), and lower education levels (25% illiterate,
31% less than high school, 24% high school, 21% associ-
ates degree or higher, p<0.0001).
In conclusion, our study demonstrated that clinics
were able to implement programs that provided indivi-
dualized education for type 2 patients with diabetes
before Ramadan and, when needed, physician-
recommended changes in the treatment regimen.
Participants who received individualized education had
better weight and HbA1c control during Ramadan and
were less likely to experience severe hypoglycemia or
hospitalization. This individualized education and dia-
betes treatment program helped patients with type 2 dia-
betes achieve a safer Ramadan fast.
Author affiliations
1
Department of Internal Medicine, University of Michigan, Ann Arbor,
Michigan, USA
2
EDC, Center for Diabetes Education, McDonough, GA, USA
3
School of Medicine, Suez Canal University, Ismailia, Egypt
4
Alexandria Faculty of Medicine, Alexandria University, Alexandria, Egypt

5
Ain Shams University, Cairo, Egypt
6
Department of Pharmacology and Nutritional Sciences, University of
Kentucky, Lexington, Kentucky, USA
7
Isalmic Hospital, Amman, Jordan
8
Dammam Medical Complex, Dammam, Saudi Arabia
9
Saudi Diabetes Research Group (SDRG), King Fahd Medical Research Center,
King Abdulaziz University, Jeddah, Saudi Arabia
10
University of Helsinki, Helsinki, Finland
11
Wayne State University, Detroit, Michigan, USA
Acknowledgements WH was supported by Grant Number P30DK092926
(The Michigan Center for Diabetes Translational Research) from the National
Institute of Diabetes and Digestive and Kidney Diseases. Publication costs
were paid by a grant from the EDC, Center for Diabetes Education,
McDonough, GA. The authors acknowledge the participation and assistance of
the physicians from the participating centers including Dr. Sawsan Isa Al-
Laham, MD (Endocrinologist, Diabetes Center Islamic Hospital, Amman,
Jordan) and Dr. Reem M El-Ailah, MD (Resident, Diabetes Center Islamic
Hospital, Amman, Jordan).
Contributors LNM researched the data and wrote the manuscript. MI, NMA,
SHA-K, HRT, GN, SM, AAM, FAA, EMB-E, SMB, JT and LAJ reviewed/edited
the manuscript. WHH contributed to the discussion and reviewed/edited the
manuscript. LNM is the guarantor of this manuscript and is responsible for
the contents of this article.
Competing interests None declared.
Ethics approval Each countries Local Ethical Standards Board; The University
of Michigan Institutional Review Board reviewed the study and determined
that the project was exempt and not regulated since it involved only coded
information that could not be linked to a specific individual by the investigator
(s) directly or indirectly through a coding system.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Request for deidentified data should be made to MI
and will be evaluated on a case-by-case basis. Deidentified data may be
available to researchers with consent of the study team, a signed data use
agreement and proper IRB approval.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. Al-Arouj M, Bouguerra R, Buse J, et al. Recommendations for
management of diabetes during Ramadan. Diabetes Care
2005;28:2305–11.
2. Al-Arouj M, Assaad-Khalil S, Buse J, et al. Recommendations for
management of diabetes during Ramadan update 2010. Diabetes
Care 2010;33:1895–902.
3. Bravis V, Hui E, Salih S, et al. Ramadan Education and Awareness
in Diabetes (READ) programme for Muslims with Type 2 diabetes
who fast during Ramadan. Diabet Med 2010;27:327–31.
4. Ahmedani MY, Haque MS, Basit A, et al. Ramadan Prospective
Diabetes Study: the role of drug dosage and timing alteration, active
glucose monitoring and patient education. Diabet Med
2012;29:709–15.
5. Siaw MYL, Chew DEK, Dalan R, et al. Evaluating the effect of
Ramadan fasting on Muslim patients with diabetes in relation to use
of medication and lifestyle patterns: a prospective study. Int J
Endocrinol 2014;2014:308546.

during Ramadan
education program on clinical outcomes
Impact of an individualized type 2 diabetes
Herman
Suhad M Bahijri, Jaakko Tuomilehto, Linda A Jaber and William H
Mohammadmoradi, Aly A Misha'l, Firas A Annabi, Ebtesam M Ba-Essa,
Assaad-Khalil, Hyam Refaat Tantawi, Gamela Nasr, Shayan
Laura N McEwen, Mahmoud Ibrahim, Nahed M Ali, Samir H
doi: 10.1136/bmjdrc-2015-000111
2015 3:BMJ Open Diab Res Care
http://drc.bmj.com/content/3/1/e000111
Updated information and services can be found at:
These include:
References
#BIBLhttp://drc.bmj.com/content/3/1/e000111
This article cites 5 articles, 2 of which you can access for free at:
Open Access
http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See:
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms,
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections
(9)Clinical care/education/nutrition/psychosocial research
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:

Ramadan Study 2015

More Related Content

What's hot

Similar to Ramadan Study 2015

More from Mahmoud IBRAHIM

Ramadan Study 2015